Louvain-la-Neuve, Belgium, June 20, 2018 --(PR.com)-- Serge Goossens joins MEDraysintell as co-author and advisor and brings his extended experience in the field of transport and handling of radiopharmaceuticals. Serge was, till 2017, the CEO of Isotopes Services International (ISI), a company that he founded in 1988. He also co-founded ISOVital in France and he was the president of EITA (European Isotopes Transport Association).

�With Serge Goossens joining MEDraysintell, we are growing a unique expert driven structure capable to help our customers better understand the complexity of the radiation healthcare industry, including nuclear medicine, radiotherapy, proton therapy and brachytherapy,� said Paul-Emmanuel Goethals, co-Founder & Partner.

MEDraysintell has started working on a new report and directory covering the transport and handling of radioactive isotopes used in nuclear medicine. This report is expected to be released by end of 2018. This document will cover the transport, packaging, handling and warehousing of radioactive isotopes, as well as reviewing the international and national regulations and security issues.

This new report will also review the training and specific competences needed in human resources within companies active in the transport of radioactive materials.

Furthermore, it will include a directory with an exhaustive profile of the several dozen of companies active in transport and handling of radioactive isotopes in the USA and Europe.

This new report and directory will be a real asset for industry insiders, finance professionals (analysts, investment bankers and M&A professionals), large international consulting firms to support their audit and to make informed decisions with unbiased and factual intelligence from high-profile experts. In particular it should become an important information tool for all the newcomers in the growing radiopharmaceutical field.

About MEDraysintell
Strategic intelligence for the radiation healthcare

Bringing value to Businesses and Investors.

MEDraysintell is a team of international experts providing first-rate strategic intelligence in nuclear medicine, radiotherapy, proton therapy and brachytherapy. We offer the most comprehensive set of reports and directories, written by specialists from the field, with over 2,100 pages of unrivaled intelligence covering some of the most exciting healthcare technologies using radiation for diagnosis and treatment. We offer client-specific intelligence in the field of radiation healthcare, with the upmost knowledge leveraging our extended network of worldwide contacts. We are proud to support numerous companies globally, helping them better understand the markets, the competitive environment, the technology development as well as the potential of merger and acquisitions (M&A). We have repeat satisfied clients operating in the field of medical radiation, investment banks and institutional investors, large international consulting firms and universities research laboratories. MEDraysintell was created in 2013 by Paul-Emmanuel Goethals and Richard Zimmermann. It combines over 70 years of experience in radiation healthcare. www.medraysintell.com